Hart RG - Search Results

1

Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.

Sharma M, Smith EE, Pearce LA, Shoamanesh A, Perera KS, Coutts SB, Damgaard D, Ameriso SF, Rha JH, Modrau B, Yoon BW, Romano M, Messé SR, Barlinn J, Lambeck J, Saad F, Berkowitz SD, Mundl H, Connolly SJ, Hart RG; NAVIGATE ESUS MIND MRI Substudy Investigators. Sharma M, et al. Among authors: hart rg. Stroke. 2022 Jan;53(1):45-52. doi: 10.1161/STROKEAHA.120.032976. Epub 2021 Sep 20. Stroke. 2022. PMID: 34538089 Clinical Trial.

2

Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies.

Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R. Coull BM, et al. Stroke. 1987 Nov-Dec;18(6):1107-12. doi: 10.1161/01.str.18.6.1107. Stroke. 1987. PMID: 3686585

3

Practical considerations in antifibrinolytic therapy.

Hart R, Coull B. Hart R, et al. Stroke. 1982 Sep-Oct;13(5):722-3. Stroke. 1982. PMID: 7123611 No abstract available.

4

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: hart rg. Circulation. 2002 Oct 8;106(15):1962-7. doi: 10.1161/01.cir.0000033220.97592.9a. Circulation. 2002. PMID: 12370220 Clinical Trial.

5

Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials.

Hart RG, Palacio S, Pearce LA. Hart RG, et al. Stroke. 2002 Nov;33(11):2722-7. doi: 10.1161/01.str.0000035735.49388.4a. Stroke. 2002. PMID: 12411668 Review.

6

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: hart rg. Circulation. 2003 Jul 1;107(25):3141-5. doi: 10.1161/01.CIR.0000077912.12202.FC. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796127 Clinical Trial.

7

Serum potassium level and dietary potassium intake as risk factors for stroke.

Hart RG, Pearce LA; Stroke Prevention in Atrial Fibrillation Investigators. Hart RG, et al. Neurology. 2003 Jun 10;60(11):1869-70; author reply 1870. doi: 10.1212/wnl.60.11.1869. Neurology. 2003. PMID: 12796561 Clinical Trial. No abstract available.

8

Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial.

Hart RG, Pearce LA, Koudstaal PJ. Hart RG, et al. Stroke. 2004 Apr;35(4):948-51. doi: 10.1161/01.STR.0000120741.34866.1D. Epub 2004 Feb 26. Stroke. 2004. PMID: 14988571 Clinical Trial.

9

Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in.

van Walraven C, Hart RG, Singer DE, Koudstaal PJ, Connolly S. van Walraven C, et al. Among authors: hart rg. Card Electrophysiol Rev. 2003 Dec;7(4):374-8. doi: 10.1023/B:CEPR.0000023143.98705.ee. Card Electrophysiol Rev. 2003. PMID: 15071258 Review.

10

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Gage BF, et al. Among authors: hart rg. Circulation. 2004 Oct 19;110(16):2287-92. doi: 10.1161/01.CIR.0000145172.55640.93. Epub 2004 Oct 11. Circulation. 2004. PMID: 15477396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters